Drug development review· 2004

AOD-9604 Metabolic

Wilding J

Current Opinion in Investigational Drugs

PubMed: 15134286
Evidence level: low
Verification: verified

Summary

Contemporary review of AOD-9604 development for obesity, including the existence of early phase clinical studies.

Limitations

Brief development review with little detailed clinical outcome reporting and no basis for modern compounded-product claims.

Linked peptides

AOD-9604

Important PeptiBrief is an educational information platform. It does not diagnose, prescribe, sell peptides, recommend dosing, encourage self-experimentation or replace qualified medical care. Published scientific evidence is kept separate from community observations and uncertainty.